Taylor Gill

Taylor Gill has a diverse work experience in the field of molecular engineering and research. They currently hold the position of Molecular Engineering Lead at HelixNano since September 2020. Prior to this role, they worked as a Vector Engineer at HelixNano from April 2018 to September 2020.

Before joining HelixNano, Taylor was a Doctoral Candidate at the MIT/Harvard Department of Health Sciences and Technology from September 2013 to December 2017. During this time, they received guidance from various advisors and conducted research in the biomedical field.

Taylor also gained research experience as an Undergraduate Research Assistant at Duke University Department of Chemistry from October 2009 to May 2013. Their research focused on synthesizing and studying the properties of nano-size polymer vesicles for targeted drug delivery and optical imaging.

In addition, Taylor worked as a Research Assistant at Columbia University Medical Center in June 2012, where they studied the effects of unsaturated fatty acid metabolites on the metastasis of human prostate cancer cells.

They also served as a Research Assistant at the Duke Clinical Research Institute from January 2012 to May 2012, where they assisted in clinical trial management and patient enrollment.

Taylor's earliest research experience was as a Research Assistant at the National Institute of Environmental Health Sciences from June 2011 to August 2011. They worked on a project investigating the influence of matrix metalloproteinase-9 on metastasis of human melanoma cancer cells.

Overall, Taylor has a strong research background and experience in various aspects of molecular engineering and biomedicine.

Taylor Gill completed a Bachelor of Science (BS) degree in Chemistry at Duke University from 2009 to 2013. They then pursued further education at the Massachusetts Institute of Technology and obtained a Doctor of Philosophy (PhD) degree in Medical Engineering and Medical Physics from 2013 to 2017.